Article Text

Download PDFPDF
Acute effects of 40% oxygen supplementation in adults with cyanotic congenital heart disease
  1. F Walker,
  2. M J Mullen,
  3. S J Woods,
  4. G D Webb
  1. University of Toronto Congenital Cardiac Centre for Adults at the Toronto General Hospital, Heart and Stroke Richard Lewar Centre of Excellence, Toronto, Ontario, Canada
  1. Correspondence to:
    Dr Fiona Walker
    GUCH Unit, 5th Floor, Middlesex Hospital, Mortimer Street, London W1N 8AA, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

This study examined the acute effects of 40% oxygen supplementation in adults with cyanotic congenital heart disease (CCHD). These young patients have significant morbidity and premature mortality, relating in part to their cyanotic state. We have shown that systemic arterial oxygen saturation (SAOS) increases significantly when these patients are administered 40% oxygen, irrespective of their underlying congenital cardiovascular diagnosis or the presence of pulmonary hypertension. Forty per cent oxygen supplementation increased SAOS above 85% in the majority of patients, with none having an SAOS less than 80%. This improvement in saturation may be clinically important because significant erythrocytosis is unusual if SAOS is greater than 85% and it is this physiological adaptation which is responsible for many of the symptoms experienced by these patients.

About 10% of adults with congenital heart disease are cyanosed and although their functional capacity is good up to the third decade, it declines along with quality of life thereafter when complications and symptoms related to the cyanotic state become more frequent. Cyanosis occurs when hypoxaemia stimulates erythropoiesis causing erythrocytosis. This re-establishes tissue oxygen delivery at the expense of an elevated haematocrit and leads to symptoms including, headaches, impaired mentation, lassitude, and myalgia, all of which have an impact …

View Full Text